Capstone Partners Advises Parity Computing on its Acquisition by Elsevier
Capstone Partners, a leading international investment banking firm, advised Parity Computing, Inc. (Parity), a California-based business that employs artificial intelligence to provide high-accuracy entity resolution, profiling and recommendations for science, technology, and medicine (STM) content and applications in the world of research, on its acquisition by Elsevier, a global information analytics business specializing in science and health.
Parity’s team brings deep academic and research experience in addition to technical expertise. We are excited to join Elsevier, and together we’ll be able to better serve researchers, universities and R&D organizations.
For over 20 years, Parity has been providing large-scale disambiguation technology in STM content, including for Elsevier’s abstract and indexing databases that help researchers, universities, national bodies and other stakeholders improve critical decision-making. With the acquisition, Parity and Elsevier will be able to build on Parity’s existing capabilities, deepen their integration, and extend them more broadly across Elsevier’s research platform.
Parity’s success is derived from the talent of its technical staff, including data scientists, software developers, and content specialists. Now, Parity’s team of computer science PhDs – all with extensive experience in machine learning, natural language processing, and semantic technologies – will join Elsevier’s research product team.
“By working more closely with Parity, we can deliver even better insights to help researchers, universities, governments and funding agencies make better decisions by enabling them to find emerging trends, increase the visibility of their research, build collaborative networks, bolster funding applications and articulate the value of research,” said Olivier Dumon, Managing Director, Research Products at Elsevier.
Founded in 1880 and headquartered in Amsterdam, Elsevier is a global information analytics business that helps scientists and clinicians to find new answers, reshape human knowledge, and tackle the most urgent human crises. They provide digital solutions and tools in the areas of strategic research management, R&D performance, clinical decision support, and professional education.